How Can ctDNA Analysis Accelerate Oncology Trials?

Abstract

Get full access to this article

View all access options for this article.

References

Atallah

et al. (2020). Assessment of outcomes after stopping tyrosine kinase inhibitors among patients with chronic myeloid leukemia: A nonrandomized clinical trial. JAMA Oncol , 7, 42–50.

van der Leest

et al. (2021). Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors. Mol Oncol , 15, 2,810–2,922.